(Q80532879)
Statements
Phase I clinical and pharmacokinetic study of 3-weekly, 3-h infusion of ixabepilone (BMS-247550), an epothilone B analog, in Japanese patients with refractory solid tumors (English)
Toshio Shimizu
Noboru Yamamoto
Yasuhide Yamada
Yasuhito Fujisaka
Kazuhiko Yamada
Kyoko Takayama
Takuto Tokudome
Judith Klimovsky